Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects
- 30 July 2009
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 16 (7), 712-723
- https://doi.org/10.1016/j.chembiol.2009.05.011
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Dihydropyridine Calcium Channel Antagonists in the Management of HypertensionDrugs, 2007
- Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancerInvestigational New Drugs, 2006
- Heart Failure Induced by Non-Cardiac DrugsDrug Safety, 2006
- Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockadeBreast Cancer Research and Treatment, 2005
- Involvement of Intracellular Ca2+ Levels in Nonsteroidal Anti-inflammatory Drug-induced ApoptosisJournal of Biological Chemistry, 2005
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- Microtubule disruption induced by estradiol in estrogen receptor-positive and -negative human breast cancer cell linesCarcinogenesis: Integrative Cancer Research, 1994
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984